Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C7H12N2O4 |
Molecular Weight | 188.1812 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)N[C@@H](CCC(N)=O)C(O)=O
InChI
InChIKey=KSMRODHGGIIXDV-YFKPBYRVSA-N
InChI=1S/C7H12N2O4/c1-4(10)9-5(7(12)13)2-3-6(8)11/h5H,2-3H2,1H3,(H2,8,11)(H,9,10)(H,12,13)/t5-/m0/s1
Molecular Formula | C7H12N2O4 |
Molecular Weight | 188.1812 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3814209Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/aceglutamide.html | https://www.ncbi.nlm.nih.gov/pubmed/26444640 | https://www.ncbi.nlm.nih.gov/pubmed/1790087 | https://www.ncbi.nlm.nih.gov/pubmed/7274416
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3814209
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/aceglutamide.html | https://www.ncbi.nlm.nih.gov/pubmed/26444640 | https://www.ncbi.nlm.nih.gov/pubmed/1790087 | https://www.ncbi.nlm.nih.gov/pubmed/7274416
Aceglutamide (INN, JAN) (brand name Neuramina), or aceglutamide aluminum (JAN, USAN) (brand name Glumal), also known as acetylglutamine, is a psychostimulant, nootropic, and antiulcer agent that is marketed in Spain and Japan. Aceglutamide functions as a prodrug to glutamine with improved potency and stability. Aceglutamide is used as a psychostimulant and nootropic, while aceglutamide aluminum is used in the treatment of ulcers. Aceglutamide can also be used as a liquid-stable source of glutamine to prevent damage from protein energy malnutrition.
CNS Activity
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1790087
700 mg bid
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28202289
Rat pheochromocytoma cell lines (PC12) were cultured in RPMI-1640 supplemented with 5% FBS and 10% HS, at 37◦C in a humidified atmosphere of 5% CO2 and 95% oxygen. The cells were incubated with Na2S2O4 at a final concentration of 10mM in the sugar and glutamine-free Earle’s solution for 4 h (hypoxia) and the cell solution was then replaced by normal medium without adding glutamine (reoxygenation). Series concentrations of Aceglutamide (0.01, 0.1, 1 and 10 mkM) were added into the culture medium 24 h after the onset of reoxygenation. Control cultures were treated in a similar way except the hypoxic challenge.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:19:49 GMT 2023
by
admin
on
Fri Dec 15 17:19:49 GMT 2023
|
Record UNII |
01J18G9G97
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
2422 (Number of products:1)
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
||
|
NCI_THESAURUS |
C47795
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C032007
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
DB04167
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
182230
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
2490-97-3
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
186896
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
1887
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
m1296
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000087914
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
01J18G9G97
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
ACEGLUTAMIDE
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
DTXSID2048959
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
C77843
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
143879
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
01J18G9G97
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
219-647-7
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
1426379
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB05208MIG
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
73685
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY | |||
|
46
Created by
admin on Fri Dec 15 17:19:49 GMT 2023 , Edited by admin on Fri Dec 15 17:19:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |